Page last updated: 2024-11-06

phentolamine and Pigmentary Retinopathy

phentolamine has been researched along with Pigmentary Retinopathy in 2 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KOMI, T1
UCHIDA, S1
Matsushita, K1
Tani, Y1
Tsumura, S1

Other Studies

2 other studies available for phentolamine and Pigmentary Retinopathy

ArticleYear
[Regitine test in the diagnosis of retinitis pigmentosa].
    Rinsho ganka. Japanese journal of clinical ophthalmology, 1961, Volume: 15

    Topics: Humans; Phentolamine; Retinitis Pigmentosa; Sympatholytics

1961
[Fundamental study on the treatment of retinitis pigmentosa. 2].
    Nihon ganka kiyo, 1966, Volume: 17, Issue:3

    Topics: Aminobutyrates; Animals; Anura; Glutamine; In Vitro Techniques; Norepinephrine; Phenelzine; Phentola

1966